Back
GeneDx Holdings Stock Predictions
Sell
46
WGS
GeneDx Holdings
Last Price:
20.59
Seasonality Move:
-30.32%
7 Day Trial
ALL ACCESS PASS
$
7
GeneDx Holdings Stock Forecast
- Over the next 52 weeks, GeneDx Holdings has on average historically risen by 20.6% based on the past 3 years of stock performance.
- GeneDx Holdings has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is GeneDx Holdings Stock Undervalued?
The current GeneDx Holdings [WGS] share price is $20.60. The Score for WGS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal. - WGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will GeneDx Holdings Stock Go Up Next Year?
- Over the next 52 weeks, GeneDx Holdings has on average historically risen by 20.6% based on the past 3 years of stock performance.
GeneDx Holdings Stock Rating
Sell
46
GeneDx Holdings (WGS)
is a Sell
Is GeneDx Holdings overpriced?
- GeneDx Holdings has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
GeneDx Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
genedx.com
52-Week Data
52-Week High:
24.40
52-Week Low:
1.16
Prediction Charts
Market Cap:
538.71M
Price in USD:
20.60
Volume:
381.86K
Beta:
2.09
Technical Analysis
SMA50:
13.99
SMA100:
9.71
SMA200:
6.39
52-Wk Change:
178%
Stock Predictions
-
Is GeneDx Holdings stock public?
Yes, GeneDx Holdings is a publicly traded company. -
What is the GeneDx Holdings stock quote today?
The GeneDx Holdings stock price is 20.60 USD today. -
How to buy GeneDx Holdings stock online?
You can buy GeneDx Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-7 | 20.07 | 19.31 | 20.65 | 18.80 |
May-8 | 18.80 | 19.27 | 20.77 | 18.80 |
May-9 | 19.19 | 20.36 | 20.71 | 19.04 |
May-10 | 20.91 | 20.75 | 21.33 | 19.56 |
May-13 | 20.82 | 23.38 | 23.73 | 20.55 |
May-14 | 23.55 | 21.35 | 23.79 | 21.29 |
May-15 | 21.30 | 21.16 | 22.20 | 21.00 |
May-16 | 22.32 | 24.02 | 24.32 | 21.50 |
May-17 | 23.85 | 22.39 | 24.40 | 22.27 |
May-20 | 21.60 | 21.76 | 22.96 | 21.26 |
May-21 | 21.70 | 20.75 | 21.92 | 20.59 |
May-22 | 20.51 | 19.99 | 21.44 | 19.88 |
May-23 | 20.29 | 19.72 | 20.71 | 19.16 |
May-24 | 19.87 | 20.60 | 20.83 | 19.49 |
GeneDx Holdings Earnings
GeneDx Holdings Earnings Report: Per Share GeneDx Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
GeneDx Holdings Forecast Revenue Growth
GeneDx Holdings Stock Analysis: Historical quarterly revenues per share for GeneDx Holdings and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.03 per share, an increase next quarter of $0.05 per share, an increase this year of $4.18 per share, and an increase next year of $0.78 per share.
* GeneDx Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.